Phenoxodiol in Treating Patients With Refractory Solid Tumors
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Phenoxodiol may stop the growth of tumor cells by blocking the enzymes necessary
for cancer cell growth.
PURPOSE: Phase I trial to study the effectiveness of phenoxodiol in treating patients who
have refractory solid tumors.